EWPI (Emerging World Pharma) Interest Expense: $ Mil (TTM As of . 20)


What is Emerging World Pharma Interest Expense?

Emerging World Pharma EWPI -98.00% Interest Expense is $ Mil as of . 20.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Emerging World Pharma's interest expense for the three months ended in . 20 was $ 0.00 Mil. Emerging World Pharma does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Emerging World Pharma's Operating Income for the three months ended in . 20 was $ 0.00 Mil. Emerging World Pharma's Interest Expense for the three months ended in . 20 was $ 0.00 Mil. Emerging World Pharma did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Emerging World Pharma  (OTCPK:EWPI) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Emerging World Pharma's Interest Expense for the three months ended in . 20 was $0.00 Mil. Its Operating Income for the three months ended in . 20 was $0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in . 20 was $0.00 Mil.

Emerging World Pharma's Interest Coverage for the quarter that ended in . 20 is calculated as

Emerging World Pharma had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Emerging World Pharma Interest Expense Historical Data

* Premium members only.

The historical data trend for Emerging World Pharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emerging World Pharma Interest Expense Chart

Emerging World Pharma Annual Data
Trend
Interest Expense

Emerging World Pharma Quarterly Data
Interest Expense

Emerging World Pharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $ Mil mean?
Emerging World Pharma (EWPI) has a Interest Expense of $ Mil as of . 20. Interest Expense is the amount a company pays on its long-term debt. View historical data on Emerging World Pharma and its competitors.
Is Emerging World Pharma's Interest Expense too high?
Emerging World Pharma's current Interest Expense is $ Mil.
How does Emerging World Pharma's Interest Expense compare to ENZB and AOXG?
Emerging World Pharma's Interest Expense of $ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Emerging World Pharma and its competitors. Emerging World Pharma's current Interest Expense is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emerging World Pharma stock overvalued right now?
Emerging World Pharma (EWPI) has a current Interest Expense of $ Mil. The current Interest Expense is $ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Emerging World Pharma (EWPI), the current Interest Expense is $ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Emerging World Pharma Business Description

Address Block 11A, Pastoral Road, Sunyani, GHA, 20109
Emerging World Pharma Inc is an investor in generic based pharmaceutical companies manufacturing within developing nations.